openPR Logo
Press release

Human Immunodeficiency Virus (HIV) Drugs Market Size 2025 by Top Key Players | AbbVie, Merck Gilead Sciences, Bristol?Myers Squibb, Janssen, GlaxoSmithKline

03-27-2020 09:39 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Study Report LLC

Human Immunodeficiency Virus (HIV) Drugs Market Size 2025 by Top

Market Study Report Has Added A New Report on Human Immunodeficiency Virus (HIV) Drugs Market That Provides A Comprehensive Review of This Industry with Respect to The Driving Forces Influencing the Market Size. Comprising the Current and Future Trends Defining the Dynamics of This Industry Vertical, This Report Also Incorporates the Regional Landscape of Human Immunodeficiency Virus (HIV) Drugs Market in Tandem with Its Competitive Terrain.

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025.? Global Human Immunodeficiency Virus (HIV) Drugs Market 2019? 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts? presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscape, and discusses major trends. The report offers the most up-to-date industry data on the actual market situation, and future outlook for global human immunodeficiency virus (HIV) drugs market. The report includes historical data from 2015 to 2018, and forecasts until 2025.

Request a sample of this premium report titled Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 ? 2025: https://www.marketstudyreport.com/request-a-sample/1629933?utm_source=openpr.com&utm_medium=Ram

The report contains a granular analysis of the present industry situations, market demands, reveals facts on the market size, revenues and provides forecasts through 2025. The report provides clear insight into current and future developments of the global human immunodeficiency virus (HIV) drugs market. The report explores detailed analysis of top 22 HIV drugs market assessment globally from 2015 to 2018 and forecasts to 2025. The report also details the latest happenings about the global research & development of HIV drugs.
Additionally, the report includes an assessment of clinical trials and promising human immunodeficiency virus (HIV) drugs in clinical development. Key trends in terms of collaboration, partnerships, and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the global human immunodeficiency virus (HIV) drugs market.

The report concludes with the profiles of major players in the global human immunodeficiency virus (HIV) drugs market. The key market players are evaluated on various parameters such as business overview and recent development.

The Major Companies Dominating this Market for its Drugs, Services and Continuous Drugs Developments are:
? AbbVie
? Merck
? Gilead Sciences
? Bristol?Myers Squibb
? Janssen (Johnson&Johnson)
? GlaxoSmithKline (GSK)

Top 22 Human Immunodeficiency Virus (HIV) Drugs Covered Under this Report are:

? Tivicay
? Triumeq
? Juluca
? Epzicom
? Selzentry
? Kaletra
? Sustiva
? Reyataz
? Atripla
? Truvada
? Viread
? Complera
? Stribild
? Genvoya
? Biktarvy
? Descovy
? Odefsey
? Prezista/Prezcobix
? Edurant
? Isentress
? Pifeltro
? Delstrigo

The Latest Industry Data Included in this Report:

? Global HIV Drugs Market Size & Analysis (2015 ? 2025)
? Global HIV Drugs Market Share & Y-o-Y Growth (%),2015 ? 2025
? Global Top 22 HIV Drugs Market Assessment & Opportunity (2015 ? 2025)
? Promising HIV Drugs in Clinical Development
? HIV Drugs Clinical Trial Insight by Phase, Institute & Country,2018
? Major Deals (Key Agreements, Partnerships & Collaborations)
? Latest Happenings in Global HIV Drugs Market
? Key Drivers & Inhibitors of the Global HIV Drugs Market
? Major Companies Analysis
The Answers to the Following Key Questions can be found in the Report:
? What is the size of the global HIV drugs market during 2015 -2025?
? What will be the revenue generated by each drug during the forecast period?
? Which major drug provides the highest market share?
? How are the overall market and major drugs growing?
? What are the key drivers and inhibitors in the current market?
? What will be the impact of drivers and inhibitors in the future?
? How is the market predicted to develop in the future?
? Who are the key players in this market space

Request a discount on standard prices of this premium report titled Global Human Immunodeficiency Virus (HIV) Drugs Market 2019? 2025: https://www.marketstudyreport.com/check-for-discount/1629933?utm_source=openpr.com&utm_medium=Ram

1. Executive Summary
2. Global HIV Drugs Market Size & Analysis (2015 ? 2025)
3. Global HIV Drugs Market Share & Y-o-Y Growth (%),2015 ? 2025
4. Latest Happenings in Global HIV Drugs Market
5. Key Drivers & Inhibitors of the Global HIV Drugs Market
5.1 Market Drivers
5.2 Inhibitors
6. Global Top 22 HIV Drugs Market Assessment & Opportunity (2015 ? 2025)
6.1 Tivicay (dolutegravir)
6.2 Triumeq (dolutegravir/abacavir/lamivudine)
6.3 Juluca (dolutegravir and rilpivirine)
6.4 Epzicom (abacavir and lamivudine)
6.5 Selzentry (maraviroc)
6.6 Kaletra (Iopinavir/ritonavir)
6.7 Sustiva (efavirenz)
6.8 Reyataz (atazanavir)
6.9 Atripla (efavirenz/emtricitabine/tenofovir)
6.10 Truvada (emtricitabine/tenofovir disoproxil fumarate)
6.11 Viread (tenofovir disoproxil fumarate)
6.12 Complera (emtricitabine, rilpivirine, and tenofovir disoproxil fumarate)
6.13 Stribild (elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate)
6.14 Genvoya (elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide)
6.15 Biktarvy (bictegravir, emtricitabine, and tenofovir alafenamide)
6.16 Descovy (emtricitabine and tenofovir alafenamide)
6.17 Odefsey (emtricitabine, rilpivirine, and tenofovir alafenamide)
6.18 Prezista/Prezcobix (darunavir ethanolate /cobicistat)
6.19 Edurant (rilpivirine)
6.20 Isentress (raltegravir)
6.21 Pifeltro (doravirine)
6.22 Delstrigo (doravirine / lamivudine / tenofovir disoproxil fumarate)
7. Partnerships, Collaboration & Licensing Agreement in Global HIV Drugs Market
8. Promising HIV Drugs in Clinical Development
9. HIV Drugs Clinical Trial Insight by Phase, Institute & Country,2018
10. Key Companies Analysis
10.1 AbbVie
10.1.1 Business Overview
10.1.2 Recent Development
10.2 GlaxoSmithKline (GSK)
10.2.1 Business Overview
10.2.2 Recent Development
10.3 Gilead Sciences
10.3.1 Business Overview
10.3.2 Recent Development
10.4 Merck
10.4.1 Business Overview
10.4.2 Recent Development
10.5 Bristol Myers Squibb
10.5.1 Business Overview
10.5.2 Recent Development
10.6 Janssen (Johnson & Johnson)
10.6.1 Business Overview
10.6.2 Recent Development

Questions? Get them answered via https://www.marketstudyreport.com/enquiry-before-buying/1629933?utm_source=openpr.com&utm_medium=Ram

Contact Us:

Market Study Report LLC

4 North Main Street,

Selbyville, Delaware 19975

USA

Phone: 1-302-273-0910

US Toll Free: 1-866-764-2150

Email: sales@marketstudyreport.com

Website: https://www.marketstudyreport.com

Blog: https://www.marketstudyreport.com/blog

About Us:
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Human Immunodeficiency Virus (HIV) Drugs Market Size 2025 by Top Key Players | AbbVie, Merck Gilead Sciences, Bristol?Myers Squibb, Janssen, GlaxoSmithKline here

News-ID: 1988672 • Views:

More Releases from Market Study Report LLC

COVID-19 Detection Kits Market Size o witness substantial growth during 2020-202 …
The research report on ‘COVID-19 Detection Kits market’ scrutinizes the current industry scenario to predict market size, market share, and projects valuation for different segmentations of the industry over 2020-2026. It provides business intelligence regarding various factors driving the industry growth in consort with discussing the challenges faced by the industry, and the approaches followed by market players to counter their impact. COVID-19 Detection Kits Market size to grow with
What's driving the Small Satellite Market trends? Raytheon, Lockheed Martin, Northrop Gruman, Dynetics, Surrey Satellite Technology, Axelspace, Sierra Nevada, Clyde Space, Planet Labs, Dauria Aerospace, CASC
What's driving the Small Satellite Market trends? Raytheon, Lockheed Martin, Nor …
Market Study Report LLC adds new research on Small Satellite market, which is a detailed analysis of this business space inclusive of the trends, competitive landscape, and the market size. Encompassing one or more parameters among product analysis, application potential, and the regional growth landscape, Small Satellite market also includes an in-depth study of the industry competitive scenario. The global Small Satellite market is valued at 1340 million US$ in 2018
What's driving the Antibiotics Market trends? Sanofi, Novartis AG, Pfizer Inc., Bayer AG, Abbott, Eli Lilly and Company. Johnson & Johnson Services, Inc., GlaxoSmithKline plc., Bristol-Myers Squibb Company, Astellas Pharma Inc.,
What's driving the Antibiotics Market trends? Sanofi, Novartis AG, Pfizer Inc., …
Market Study Report LLC has added a new report on Antibiotics market that provides a comprehensive review of this industry with respect to the driving forces influencing the market size. Comprising the current and future trends defining the dynamics of this industry vertical, this report also incorporates the regional landscape of Antibiotics market in tandem with its competitive terrain. The antibiotics was valued at US$ 43,348.38 million in 2019 and is
What's driving the Electrical House (E-House) Market trends? Schneider Electric, ABB, Siemens, Eaton and General Electric
What's driving the Electrical House (E-House) Market trends? Schneider Electric, …
Market Study Report LLC has added a new report on Electrical House (E-House) market that provides a comprehensive review of this industry with respect to the driving forces influencing the market size. Comprising the current and future trends defining the dynamics of this industry vertical, this report also incorporates the regional landscape of Electrical House (E-House) market in tandem with its competitive terrain. Electrical House (E-House), also called Power House, is

All 5 Releases


More Releases for HIV

HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Introduction to Human Immunodeficiency Virus (HIV) Vaccines 1.1 Overview 1.2 Antiquity of HIV Vaccine Need for the Development of HIV Vaccine Primer of HIV inside the Body 3.1 Inclusion of HIV Virus into the System 3.2 Interaction of HIV with Host 3.3 Eradication of HIV Virus HIV Vaccine Development Process 4.1 Introduction
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways
Hidden HIV Revealed: New Insights Into Latent HIV Infections
In spite of ever more effective therapies, HIV keeps managing to survive in the body. A comprehensive project conducted by the Austrian Science Fund FWF has clarified the molecular processes which contribute to this effect. In the process, approaches were discovered for possible therapies to combat the hidden reservoir formed by the virus. Thanks to modern therapies, HIV infections have become controllable – but these treatments cannot provide a cure. Antiretroviral